Predicting HER2 amplification in breast cancers with equivocal HER2 immunohistochemistry.
- DOI
- 10.1016/j.anndiagpath.2026.152699
- Published
- 2026 Dec
- Container
- Annals of diagnostic pathology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.anndiagpath.2026.152699,
title = {Predicting HER2 amplification in breast cancers with equivocal HER2 immunohistochemistry.},
author = {Den J and Polychronopoulou E and Baughn C and He J and Dong J and Klimberg VS},
year = {2026},
journal = {Annals of diagnostic pathology},
doi = {10.1016/j.anndiagpath.2026.152699},
url = {https://doi.org/10.1016/j.anndiagpath.2026.152699}
}RIS
TY - JOUR TI - Predicting HER2 amplification in breast cancers with equivocal HER2 immunohistochemistry. AU - Den J AU - Polychronopoulou E AU - Baughn C AU - He J AU - Dong J AU - Klimberg VS PY - 2026 JO - Annals of diagnostic pathology DO - 10.1016/j.anndiagpath.2026.152699 UR - https://doi.org/10.1016/j.anndiagpath.2026.152699 ER -
APA
J, D., E, P., C, B., J, H., J, D., & VS, K. (2026). Predicting HER2 amplification in breast cancers with equivocal HER2 immunohistochemistry.. Annals of diagnostic pathology. https://doi.org/10.1016/j.anndiagpath.2026.152699
Source records
- pubmed · retrieved 2026-09-25T08:52:36.702Z